Cryo-Save Group N.V. - Strong results: revenue up 5% to ?40.4 million and operating profit up 92% to ?4.5 million
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international family stem cell bank, has published its financial results for the
year ended 31 December 2010.
Financial highlights
* Revenue up 5% to ?40.4 million (2009: ?38.4 million)
* EBITA* up 63% to ?5.8 million (2009: ?3.6 million)
* Operating profit up 92% to ?4.5 million (2009: ?2.3 million)
* Profit before taxation up 117% to ?3.9 million (2009: ?1.8 million)
* Net profit up 89% to ?2.6 million (2009: ?1.4 million)
* Basic earnings per share 27.6 euro cents (2009: 14.6 euro cents)
* Net cash from operating activities ?2.8 million (2009: ? 4.8 million)
* Cash position of ?6.0 million as at 31 December 2010
* Stringent cost control resulting in increased operational leverage
* Dividend per share of ?0.07 up 17% (2009: ?0.06)
* EBITA is defined as Earnings Before Interest, Taxation and Amortization of
identified intangible assets
Operational highlights
* Strengthened market position and product portfolio in key markets
* Over 38,000 new samples stored in 2010 (2009: 32,000): 26,300 new cord blood
samples and 12,000 new cord tissues
* Over 170,000 samples stored in total
* Over 60% of new customers now opting for the combined service of cord blood
and cord tissue storage, where available
* Successful introduction of Cryo-Lip® in Europe
* Acquisition of the Bulgarian distributor Tissue Bank Cryo Center Bulgaria AD
* Another sample released in 2010 for a six year old Portuguese boy
participating in an FDA approved clinical trial for the treatment of
Cerebral Palsy at Duke University in the US
* 10 year anniversary of storing the first samples of umbilical cord blood
stem cells
Cryo-Save has achieved its ?40 million revenue milestone, along with strong
financial results overall. Revenue grew 5% from ?38.4 million in 2009 to ?40.4
million in 2010 mainly due to the uptake of the combined service of cord blood
and cord tissue storage with higher revenue per sample. Operating profit was up
92% to ?4.5 million, from ?2.3 million in 2009, as a result of stringent cost
control and higher one off charges in the previous year. The number of new
samples stored increased from 31,500 in 2009 to 38,300 in 2010, due to the
successful uptake of cord tissue storage
Arnoud van Tulder, Chief Executive, commented:
"These strong results demonstrate the sound fundamentals on which we have built
our business. The ability to leverage our state-of-the-art processing and
storage facilities, along with our strong track record in the logistics of
collecting and releasing samples has contributed to our solid performance.
"Cryo-Save has expanded its services. By now offering the storage of stem cells
from adipose tissue and umbilical cord tissue in addition to stem cells from
umbilical cord blood, we have further strengthened our leadership in this
industry sector".
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Christopher Theis
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com
About Cryo-Save
With over 170,000 samples saved, Cryo-Save is the leading international family
stem cell bank. Driven by its international business strategy, Cryo-Save is now
represented in 40 countries on three continents with state-of-the-art processing
facilities in Belgium, Germany, Dubai, India and France (validation in
progress).
Download Full Release:
http://hugin.info/143308/R/1498535/434127.pdf
Download Full Year Results Presentation:
http://hugin.info/143308/R/1498535/434128.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1498535]
Unternehmensinformation / Kurzprofil:
Datum: 22.03.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 52626
Anzahl Zeichen: 5084
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 237 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V. - Strong results: revenue up 5% to ?40.4 million and operating profit up 92% to ?4.5 million"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
